About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
+13 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Technicals
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Profit & Loss
Concord Biotech Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:
543960
NSE Symbol:
CONCORDBIO
P/E :
46.41
ISIN Demat:
INE338H01029
Div & Yield %:
0.55
EPS :
34.15
Book Value:
173.27
Market Cap (Rs. Cr.):
16,581.67
Face Value :
1
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
1,200.09
1,016.94
853.17
712.93
616.94
512.33
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,200.09
1,016.94
853.17
712.93
616.94
512.33
Other Income
44.45
33.78
35.31
23.42
13.81
31.37
Stock Adjustments
14.79
12.08
15.63
23.98
39.05
4.85
Total Income
1,259.33
1,062.80
904.11
760.33
669.80
548.55
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
320.30
241.28
195.84
187.99
150.61
134.79
Power & Fuel Cost
112.23
104.97
97.65
71.64
39.86
37.30
Employee Cost
138.93
123.05
110.28
95.69
69.47
62.24
Other Manufacturing Expenses
26.18
28.00
24.93
17.10
12.99
30.93
Selling & Administrative Expenses
99.31
91.08
82.93
67.90
44.87
31.74
Miscellaneous Expenses
11.09
8.46
13.20
22.66
10.26
15.65
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
708.03
596.83
524.84
462.99
328.05
312.65
Operating Profit
551.29
465.97
379.27
297.34
341.74
235.91
Interest
1.04
3.18
5.18
6.13
1.05
1.17
Gross Profit
550.25
462.79
374.09
291.21
340.69
234.74
Depreciation
54.37
53.59
54.03
50.05
27.52
21.25
Profit Before Tax
495.88
409.20
320.06
241.16
313.17
213.49
Tax
118.96
99.83
79.53
58.49
75.72
54.53
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
3.95
4.63
2.40
4.10
2.11
-10.00
Reported Net Profit
372.96
304.73
238.13
178.57
235.33
168.96
Extraordinary Items
16.58
10.48
2.70
3.86
5.24
17.47
Adjusted Net Profit
356.38
294.25
235.43
174.71
230.09
151.49
Adjustment below Net Profit
5.97
-0.01
0.26
-0.56
-0.04
-0.84
P & L Balance brought forward
1,403.60
1,170.33
985.51
878.02
648.43
560.85
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
91.54
71.45
53.56
70.52
5.71
80.55
P & L Balance carried down
1,691.00
1,403.60
1,170.33
985.51
878.02
648.43
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
875.00
875.00
683.00
51.20
0.00
392.50
Dividend Per Share(Rs)
10.70
8.75
6.83
5.12
0.00
39.25
Earnings Per Share-Unit Curr
35.65
29.13
22.76
187.76
247.44
177.66
Earnings Per Share(Adj)-Unit Curr
35.65
29.13
22.76
187.76
247.44
177.66
Book Value-Unit Curr
173.27
145.80
123.50
1,164.13
1,051.11
809.71
Book Value(Adj)-Unit Curr
173.27
145.80
123.50
1,164.13
1,051.11
809.71